Principal Display Panel (5 mg Tablet Bottle Label)
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Tablet
Product Images NDC 57664-644
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate (NDC 57664-644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (7.5 mg Tablet Bottle Label)
This is a medication guide for a mixed salts of a single entity amphetamine product consisting of Dextroamphetamine Saccharate, Amphetamine Aspartate, and Amphetamine Sulfate Tablets. It is available in the form of 100 tablets which require a prescription to purchase. It also contains a NDC (National Drug Code) number for identification in the medical industry.*
Principal Display Panel (10 mg Tablet Bottle Label)
Principal Display Panel (12.5 mg Tablet Bottle Label)
Principal Display Panel (15 mg Tablet Bottle Label)
Principal Display Panel (20 mg Tablet Bottle Label)
Principal Display Panel (30 mg Tablet Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
